Home Guides
Tirzepatide Guides
Dosing, side effects, switching, insurance, storage and the pricing structures that decide your year.
Every guide
Tirzepatide Dosage Chart 2026
Tirzepatide starts at 2.5 mg once weekly and steps up by 2.5 mg no sooner than every four weeks, through 5, 7.5, 10, 12.5 and 15 mg. The 2.5 mg starter dose is …
Tirzepatide Results Timeline
Most people notice reduced appetite within the first two weeks, see the scale move meaningfully between weeks 4 and 12, and reach the steepest part of the curve…
Tirzepatide Side Effects
Nausea affects roughly 24–33% of people, diarrhea 19–23%, constipation 16–17% and vomiting 8–12%. Effects cluster in the days after a dose increase and usually …
Tirzepatide vs Semaglutide 2026
In the only large randomized head-to-head, SURMOUNT-5, tirzepatide produced 20.2% mean weight loss versus 13.7% for semaglutide over 72 weeks — roughly 47% more…
Switching From Semaglutide to Tirzepatide
There is no 1:1 dose conversion between the molecules. You restart at 2.5 mg tirzepatide weekly regardless of your current semaglutide dose, take the first tirz…
Flat vs Dose-Scaled Tirzepatide Pricing
Most advertised tirzepatide prices quote the 2.5 mg starter tier — a dose you occupy for exactly four weeks. Programs that scale price with dose can more than d…
Is Compounded Tirzepatide Legal in 2026? What Changed and What Didn't
Compounded tirzepatide remains legal when a state-licensed 503A pharmacy prepares it for an individual patient with a valid prescription. What ended in 2025 was…
Zepbound Cost 2026
Brand Zepbound lists around $1,089 per month at retail. Real-world cash cost ranges from $25 with commercial insurance plus the savings card, to $50 on the Medi…
Tirzepatide Without Insurance
Without insurance, compounded tirzepatide from a licensed US 503A pharmacy runs roughly $99–$299 per month. Brand-name Zepbound through LillyDirect self-pay run…
How to Inject Tirzepatide
Tirzepatide is injected subcutaneously once weekly into the abdomen at least two inches from the navel, the front or outer thigh, or the back of the upper arm. …
Tirzepatide Plateau
A plateau is three or more consecutive weeks with no downward trend — not a flat week or a two-pound fluctuation. The three fixable causes, in order: you are st…
How to Verify a Tirzepatide Provider
A legitimate program names its pharmacy, names its prescriber, requires a real clinical review, publishes total cost at every dose, and is willing to tell you n…
Counterfeit and Grey-Market Tirzepatide
Counterfeit tirzepatide is a real and documented problem. The tells are price far below the market floor, no prescription requirement, 'research use only' label…
Tirzepatide and Alcohol
There is no direct drug interaction between tirzepatide and alcohol, and the label carries no alcohol warning. But alcohol can worsen nausea, raises hypoglycemi…
Storing and Traveling With Tirzepatide
Store tirzepatide refrigerated at 36–46°F. Never freeze it and never use a vial or pen that has frozen. Compounded vials commonly carry a 28-day beyond-use date…
Protecting Muscle on Tirzepatide
A substantial fraction of weight lost during rapid loss is lean mass unless you intervene. Adequate protein and resistance training two to three times weekly ar…
Getting Tirzepatide Covered
A large share of first-pass prior authorisation requests are denied, and most denials are reversible. The four documentation gaps that trigger most denials are …
Your First 30 Days on Tirzepatide
Set a fixed weekly injection day, expect appetite change before scale change, front-load protein and water, and treat the 48 hours after each dose as the window…
Food Noise on Tirzepatide
'Food noise' is the intrusive, repetitive mental preoccupation with eating that many people with obesity describe. It is one of the first things tirzepatide cha…
Tirzepatide Microdosing
Microdosing means using doses below the 2.5 mg starter — often 1 mg or less weekly. There is no randomized trial evidence supporting it for weight management. I…
Oral Tirzepatide and the Needle-Free Options
There is no FDA-approved oral tirzepatide. Compounded sublingual and oral dissolvable tirzepatide exists, but bioavailability data for these formulations is lim…
Facial Volume Loss on Tirzepatide
So-called 'Ozempic face' is not drug-specific. Rapid weight loss depletes subcutaneous facial fat, which sits closer to the surface than trunk fat and therefore…
Tirzepatide, Pregnancy and Contraception
Tirzepatide is not recommended in pregnancy. It may also reduce the effectiveness of oral contraceptives because it delays gastric emptying — the label advises …
Tirzepatide for PCOS
Tirzepatide is not FDA-approved for polycystic ovary syndrome, but it directly addresses the insulin resistance that drives PCOS-associated weight gain, cycle i…
Zepbound vs Mounjaro vs Compounded
Zepbound and Mounjaro are the identical molecule from the identical manufacturer at identical strengths. The difference is the FDA label — Mounjaro for type 2 d…
Tirzepatide Drug Interactions Worth Knowing
The interactions that matter most are with insulin and sulfonylureas (hypoglycemia risk), oral contraceptives (reduced absorption), and any oral medication with…
The Real Twelve-Month Cost of Tirzepatide
Assume four weeks at 2.5 mg, four weeks at 5 mg, and the remaining ten months at a maintenance dose. On a flat-rate compounded program at $179 that is about $2,…
Primary sources
Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.
- ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
- FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
- The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.